/PRNewswire/ Instylla, Inc., a privately held company developing next-generation liquid embolics for peripheral vascular embolotherapy, today announced the.
Single Pass Inc., a Lake Forest medical device developer, has commenced treatment with the Kronos Electrocautery device on its first patients in North America.
/PRNewswire/ Single Pass, Inc. CEO, Bill Colone, announced treatment of the first patients in North America with the Kronos Electrocautery device designed.